Is Entresto still in shortage in 2026? Get the latest update on Entresto availability, generic options, Medicare pricing changes, and how to find it in stock.
If you take Entresto for heart failure, you've probably heard the headlines: generic versions are here, Medicare has negotiated a lower price, and the drug landscape is shifting fast. But what does all of this actually mean for you — the patient trying to fill a prescription?
This guide breaks down the current state of Entresto availability in 2026, explains what's behind any supply issues you might encounter, and tells you exactly what to do if your pharmacy can't fill your prescription.
As of early 2026, there is no official FDA-listed shortage of Entresto or generic Sacubitril/Valsartan. This is good news. However, that doesn't mean every pharmacy has it on the shelf at all times.
Many patients are still running into difficulty finding Entresto at their local pharmacy. These localized stock-outs are different from a national shortage — they happen when demand at a particular pharmacy exceeds its supply, even though the drug is generally available through the supply chain.
The situation has improved significantly compared to previous years, largely thanks to the availability of generic Sacubitril/Valsartan from multiple manufacturers. But the transition period has created some short-term disruption.
Even without a formal shortage, several factors can make it difficult to get your Entresto prescription filled:
Entresto's core U.S. patent expired in July 2025, and the FDA began approving generic versions of Sacubitril/Valsartan in mid-2024. Multiple generic manufacturers are now producing the drug. However, this transition creates a messy middle period where:
Heart failure affects approximately 6 million Americans, and Entresto is increasingly recommended as a first-line treatment by cardiologists and heart failure guidelines. Novartis reported $7.8 billion in Entresto sales in 2024 — demand hasn't slowed down even with generics entering the market.
Sacubitril/Valsartan isn't a simple pill to make. It requires co-crystallization of two active pharmaceutical ingredients in precise ratios. This complexity can slow generic production ramp-up and make the supply chain more susceptible to disruptions.
The cost picture for Entresto has changed dramatically. Here's a quick breakdown:
For more details on saving money, see our complete guide on how to save money on Entresto in 2026.
This is the biggest change. Generic Sacubitril/Valsartan is FDA-approved and bioequivalent to brand-name Entresto. It's available in all three strengths (24/26 mg, 49/51 mg, and 97/103 mg) and is significantly cheaper. If your pharmacy is out of brand-name Entresto, ask about the generic — it may be in stock even when the brand isn't.
If you're on Medicare Part D, the negotiated price of approximately $295 per month (plus your plan's cost-sharing) represents a significant reduction from the brand-name list price. Additionally, the $2,000 annual out-of-pocket cap on Part D spending (which took effect in 2025) provides further protection for Medicare beneficiaries who take expensive medications.
Current guidelines now emphasize four pillars of heart failure treatment: an ARNI (like Entresto) or ACE inhibitor/ARB, a beta blocker, a mineralocorticoid receptor antagonist (like Spironolactone), and an SGLT2 inhibitor (like Farxiga or Jardiance). If Entresto isn't available, your doctor has more evidence-based options than ever to build an effective treatment plan.
If your pharmacy doesn't have Entresto, here's what to do:
For more strategies, read our full guide on how to find Entresto in stock near you.
The Entresto landscape is changing for the better in 2026. Generic options are bringing prices down, Medicare negotiation is capping costs for seniors, and the supply situation is stabilizing as more manufacturers enter the market.
But if you're one of the patients caught in the transition — dealing with a temporary stock-out or navigating insurance changes — know that there are resources to help. Start with Medfinder to find your medication, and talk to your doctor if you have questions about switching to the generic or exploring alternative treatments.
Your heart failure management is too important to leave to chance. Stay proactive, plan ahead, and don't hesitate to reach out for help.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
